| Dr Mohamad Imad Haque, MD | |
|
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
| (425) 502-3000 | |
| (425) 502-3589 |
| Full Name | Dr Mohamad Imad Haque |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 26 Years |
| Location | 11511 Ne 10th St, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326074345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD00039068 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Evergreenhealth Home Care | Kirkland, WA | Home health agency |
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Overlake Medical Clinics Llc | 7012808827 | 350 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Overlake Medical Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801828421 PECOS PAC ID: 7012808827 Enrollment ID: O20040322001533 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609061969 PECOS PAC ID: 8820178288 Enrollment ID: O20080110000429 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Entity Name | Valley Medical Group-renton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619209574 PECOS PAC ID: 4183753965 Enrollment ID: O20100604000113 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohamad Imad Haque, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 | Dr Mohamad Imad Haque, MD 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 |
News Archive
Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one organ to another organ and improve the effectiveness of vaccines.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Patients experienced a greater occurrence of infections in the years preceding a cancer diagnosis.
A seminal study by US researchers, currently available on the bioRxiv* preprint server, demonstrates how structure-based design can be efficiently employed to develop molecular probes targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike and its domains, with possible future use in diagnostics, treatment and vaccine development.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
› Verified 6 days ago
David W Nelson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1135-116th Avenue Ne, Suite 605, Bellevue, WA 98004 Phone: 425-454-8161 Fax: 425-454-6304 | |
April Phantana-angkool, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne Ste 200, Bellevue, WA 98004 Phone: 425-688-0212 Fax: 425-688-0213 | |
Eiji Minami, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1135 116th Ave Ne, Suite 550, Bellevue, WA 98004 Phone: 425-688-1916 Fax: 425-688-1901 | |
Sooyeon Kim, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1135 116th Ave Ne Ste 305, Bellevue, WA 98004 Phone: 425-453-1772 | |
Mrs. Eileen T. Consorti, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne Ste 200, Bellevue, WA 98004 Phone: 425-688-0212 | |
Dudley T Moorhead Ii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1135 116th Ave Ne Ste 220, Bellevue, WA 98004 Phone: 425-450-7007 Fax: 425-450-0026 |